Engineers Gate Manager’s Day One Biopharmaceuticals DAWN Stock Holding History

Engineers Gate Manager’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,093	Closed	-$624K	–	2314
2026 Q1	$624K	Buy	+29,093	New	+$410K	0.01%	1281
2025 Q2	–	Sell	-17,291	Closed	-$137K	–	2225
2025 Q1	$137K	Buy	+17,291	New	+$186K	﹤0.01%	1964

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's DAWN Position: Q2 2026 in Review

Engineers Gate Manager sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 29,093 shares — an estimated $624K sold.

Engineers Gate Manager first reported a position in DAWN in Q1 2025 and held it in 2 quarters. The position peaked at $624K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Engineers Gate Manager reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 29,093 Day One Biopharmaceuticals shares in Q2 2026, an estimated $624K.
Engineers Gate Manager first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 2 quarters.
Engineers Gate Manager's Day One Biopharmaceuticals position peaked at $624K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.